DewDiligence - biotech indexes,
I don’t pay a lot of attention to these indexes, so I don’t know offhand what accounts for the aforementioned disparity. Do you?
Not really but I expect it is average size of the biotechs. Jim McCamant many years ago recommended using the AMEX index because it better reflected the overall market. I could see why he would say that with his wild recommendations.
An interesting counterpoint to current conventional wisdom. Cynthia Robbins-Roth advised that the most money was made buying biotechs with the lead drug in Phase II complete with graphs and charts. It was not, of course, just coincidental that that was where the greatest dropout rate occurred.
There are huge gains regularly on the OTC market from most unlikely prospects. There are even some nifty biotechs amongst the bric-a-brac. Good to be most selective I think but if you are just looking for a quick score I guess ShazamStocks is a better guide than Cynthia Robbins-Roth. :-)
Best, Terry
Market Data 
Markets 
AI
